Bardzo tanie apteki z dostawą w całej Polsce kupic levitra i ogromny wybór pigułek.

Fsc_companion 2012.vp

Venture Capital & Private Equity / Canadian Firms
ALBERTA ENTERPRISE CORPORATION
Suite 1100
10830 Jasper Avenue
Edmonton, AB T5J 2B3
Canada

Phone: 780-392-3901 Fax: 780-392-3908
e-mail: [email protected]
web: www.alberta-enterprise.ca
Mission Statement: To fund and foster new venture capital fund managers in Alberta and to develop
and support the startup community to ensure quality deal flow.
Geographic Preference: Alberta
Fund Size: $100 million
Founded: 2008
Industry Group Preference: Software, Internet, Media, Manufacturing, Clean Technology, Energy,
Medical Devices, Life Sciences, Pharmaceuticals, Electronics
Portfolio Companies: iNovia Capital, Chrysalix Energy Venture Capital, Yaletown Venture Partners
Key Executives:
Rod Charko, Chief Executive Officer
Education: BSc, University of Calgary; MSc, Engineering, University of Washington; MBA,
University of Western Ontario
Background: Advisor, BDC Venture Capital
Rebecca Giffen, Director of Investments
Education: BComm, Haskayne School of Business, University of Calgary
Background: Director of Fund Investments, BDC Venture Capital
Carey Houston, Director of Industry Development
Education: BComm, University of Alberta; MBA, Richard Ivey School of Business
Kristina Williams, Director of Investments
Education: Master of Laws, Uppsala University; MBA, University of Alberta
Background: Director of Marketing, Cevena Bioproducts; VP Marketing, Natraceutical Canada
ALBERTA INVESTMENT MANAGEMENT CORP.
1100-10830 Jasper Avenue
Edmonton, AB T5J 2B3
Canada

Phone: 780-392-3600
e-mail: [email protected]
web: www.aimco.alberta.ca
Mission Statement: Operating on commercial principles with a strong Board, AIMCo is determined to
produce superior, long-term investment results without taking unacceptable risks. Our evolution from a
division of government to a Crown corporation is critical to good governance and sound investment
decisions. That will put us in a better position to meet the evolving needs of our clients, respond to
market changes and compete and excel in a competitive global marketplace.
Founded: 2008
Portfolio Companies: Axcan Pharma, CCS, Cengage, Ceridian, DGAM, Generac, GLM, KMC,
RTL-Westcan
Key Executives:
Leo De Bever, CEO/Chief Investment Officer
Education: BA, Economics, University of Oregon; MA, PhD, University of Wisconsin,
Madison
Venture Capital & Private Equity / Canadian Firms
Mission Statement: To build Canada’s next generation of global business success stories.
Geographic Preference: Canada
NORTHLEAF CAPITAL PARTNERS
79 Wellington Street West
6th Floor, Box 120
Toronto, ON M5K 1N9
Canada

Fax: 416-304-0195
Toll-Free: 866-964-4141
e-mail: [email protected]
web: www.northleafcapital.com
Mission Statement: Northleaf is a global private markets investor with strong Canadian roots and a long
history of superior investment returns. We are committed to building enduring relationships with our
investors, fund managers, business partners and colleagues based on trust, respect, and the highest
standards of integrity and professionalism.
Geographic Preference: North America, Europe, Asia
Fund Size: 3.7 billion
Investment Criteria: Venture & Growth Equity, Buyouts, Special Situations
Other Locations:
14 Waterloo Place
4th Floor
London SW1Y 4AR
United Kingdom
Phone: 44-20-7321-5750 Fax: 44-30-7930-7171
3000 Sand Hill Road
Building 1, Suite 230
Menlo Park, CA 94025
Phone: 650-234-9810 Fax: 650-234-9859
Key Executives:
David Austin, Managing Director
e-mail: [email protected]
Education: AB, Harvard University; BA, Law, Master’s in Law & Economics, Oxford
University
Background: TD Capital Private Equity, BMO Nesbitt Burns
Daniel Dupont, Managing Director
e-mail: [email protected]
Education: BBA, MBA, International Finance, HEC Montreal; CA
Background: Coller Capital, National Bank of Canada
Michael Flood, Managing Director
e-mail: [email protected]
Education: BA, Queen’s Univeristy; MS, Indiana University; MBA, Richad Ivey School of
Business
Background: TD Capital Private Equity, Harrowston, Royal Bank Capital Partners
Gavin Foo, Chief Financial Officer
e-mail: [email protected]
Education: BComm, University of Toronto; CA
Background: TD Capital Private Equity; SVP/CFO, IA Clarington Investments; Trimark
Financial Corporation; Coopers & Lybrand
Melissa McJannet, Managing Director
e-mail: [email protected]
Education: BA, Queen’s University; MBA, Stanford Graduate School of Business
Background: TD Captial Private Equity; Associate, Mayfield; RBC Dominion
College/University Index / Amos Tuck School of Business
Amos Tuck School of Business
Haskayne School of Business
Bangalore University
Dartmouth College
Henley Management College
Bishop’s University
DeGroote School of Business
Hong Kong Polytechnic University
Boston College
ESADE Business School
Hull University
Boston University
Ecole Polytechnique Montreal
Bowdoin College
Emory University
Evan McCordick, 40Loudon Mclean Owen, 109 Bowling Green State University
Fordham University
Indiana University
Brandeis University
Georgetown University
John Carroll University
Brown University
John Molson School of Business
Bucknell University
Johns Hopkins University
HEC Business School
California Institute of Technology
Kellogg School of Management
HEC Montreal
Cambridge University
Carleton University
Paul Chiarelli, 162
HEC Paris
L’Ecole Polytechnique
Harvard Business School
Lakehead University
College of William & Mary
Laurential University
Columbia Business School
Laurentian University
Columbia University
Laval University
Concordia University
Lehigh University
London School of Business
Cornell University
Harvard University
London School of Economics
Dalhousie Law School
London University
Dalhousie University
Loyola College
Executive Name Index
Geographic Index / Canada
BIOENTERPRISE, 19BIRCH HILL EQUITY PARTNERS, 20 CANADIAN VENTURE CAPITAL ASSOCIATION, 2456 EMERALD TECHNOLOGY VENTURES, 55ENERTECH CAPITAL, 516 MARS CLEANTECH FUND, 101MARS INVESTMENT ACCELERATOR FUND, 102 MEDWELL CAPITAL, 105MERCATOR INVESTMENTS, 106 MONITOR GROUP Monitor Company Canada, 952 NSBI VENTURE CAPITAL Nova Scotia Business Inc., 116 NEWHAVEN CORPORATE FINANCE LIMITED, 111NFQ VENTURES, 113 Industry Preference Index / Advanced Manufacturing
Advanced Manufacturing
Building Materials & Services
SCOTIABANK PRIVATE EQUITY, 137XPV CAPITAL, 167 Advanced Materials
EMERALD TECHNOLOGY VENTURES, 55
Business Services
Advanced Technologies
NEWHAVEN CORPORATE FINANCE LIMITED, 111PARKVIEW CAPITAL PARTNERS, 124 Advertising
SCOTIABANK PRIVATE EQUITY, 137SIGNAL HILL EQUITY PARTNERS, 139 Aerospace
NSBI VENTURE CAPITAL Nova Scotia Business Inc., 116 WESTCAP MGT, 163WESTERN AMERICA CAPITAL GROUP, 164 Agricultural Technologies
Business to Business
Agriculture
FCC VENTURES Farm Credit Canada, 60FORAGEN TECHNOLOGIES MANAGEMENT, 63 Capital Equipment
Chemicals
TORQUEST PARTNERS, 149
All Sectors Considered
CLAIRVEST GROUP, 38
Clean Technology
BC RENAISSANCE CAPITAL FUND, 13BDC VENTURE CAPITAL Business Development Bank of Canada, 14 Alternative Energy
EMERALD TECHNOLOGY VENTURES, 55GROWTHWORKS, 71 Animal Science
LIONS CAPITAL CORP, 95MACKIE RESEARCH CAPITAL CORPORATION, 97 MARS INVESTMENT ACCELERATOR FUND, 102MMV CAPITAL PARTNERS, 107 Applications Software & Services
NSBI VENTURE CAPITAL Nova Scotia Business Inc., 116 OMERS VENTURES, 119ONTARIO CAPITAL GROWTH CORPORATION, 122 Automotive
TANDEM EXPANSION FUND, 142TERALYS CAPITAL, 148 Aviation
WELLINGTON FINANCIAL, 160YALETOWN VENTURE PARTNERS, 168 Biopharmaceuticals
CTI LIFE SCIENCES FUND, 45
Cloud Computing
Commercialization
Biotechnology
DYNEX CAPITAL CORPORATION, 51FCC VENTURES Farm Credit Canada, 60 Communications
BDC VENTURE CAPITAL Business Development Bank of Canada, 14 CIBC CAPITAL PARTNERS, 37DISCOVERY CAPITAL CORPORATION, 49 Broadband
JEFFERSON PARTNERS, 87KILMER CAPITAL PARTNERS, 92 Portfolio Companies Index

Source: http://www.greyhouse.ca/pdf/CDNventure_pgs.pdf

productstewardship.eu

Official Journal of the European Communitiesadapting to technical progress for the 27th time Council Directive 67/548/EEC on theapproximation of laws, regulations and administrative provisions relating to the classification,packaging and labelling of dangerous substances(*)THE COMMISSION OF THE EUROPEAN COMMUNITIES,Having regard to the Treaty establishing the EuropeanThe texts in Annexes I a

Fakta: schizofreni

Fakta schizofreni 1. Psykossjukdomar I Sverige insjuknar mellan 1 500 och 2 000 personer varje år i psykos varav schizofreni är den vanligaste formen. En psykos kan definieras som ett tillstånd där en persons verklighetsuppfattning är förändrad med symtom som hallucinationer, förföljelsemani, svårigheter att tänka och bristande sjukdomsinsikt. Det är oklart vad som orsak

Copyright © 2010-2014 Medical Articles